Aspen Aerogels (NYSE:ASPN) Shares Down 5.2% – Should You Sell?

Aspen Aerogels, Inc. (NYSE:ASPN) shares fell 5.2% during trading on Thursday . The company traded as low as $6.98 and last traded at $6.97. 733,678 shares traded hands during mid-day trading, a decline of 59% from the average session volume of 1,785,620 shares. The stock had previously closed at $7.35.

Analyst Ratings Changes

A number of research firms have recently commented on ASPN. Canaccord Genuity Group lowered their target price on Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating for the company in a research note on Friday, February 14th. TD Cowen upgraded Aspen Aerogels to a “strong-buy” rating in a research note on Tuesday, March 11th. Barclays lowered their price objective on Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating for the company in a research note on Wednesday, February 19th. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a research note on Wednesday, February 19th. Finally, Seaport Res Ptn lowered Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 12th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $19.11.

Aspen Aerogels Stock Up 1.8 %

The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The company has a market cap of $578.93 million, a P/E ratio of 44.10 and a beta of 2.28. The company has a fifty day moving average of $9.61 and a 200 day moving average of $15.40.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. On average, research analysts anticipate that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current fiscal year.

Institutional Trading of Aspen Aerogels

Several hedge funds have recently bought and sold shares of the stock. Abbot Financial Management Inc. grew its holdings in Aspen Aerogels by 3.9% during the fourth quarter. Abbot Financial Management Inc. now owns 30,255 shares of the construction company’s stock valued at $359,000 after purchasing an additional 1,146 shares during the period. Franklin Resources Inc. grew its holdings in Aspen Aerogels by 5.3% during the third quarter. Franklin Resources Inc. now owns 29,418 shares of the construction company’s stock valued at $815,000 after purchasing an additional 1,483 shares during the period. Invesco Ltd. grew its holdings in Aspen Aerogels by 3.5% during the fourth quarter. Invesco Ltd. now owns 50,871 shares of the construction company’s stock valued at $604,000 after purchasing an additional 1,724 shares during the period. Greenwood Capital Associates LLC grew its holdings in Aspen Aerogels by 5.0% during the fourth quarter. Greenwood Capital Associates LLC now owns 36,938 shares of the construction company’s stock valued at $439,000 after purchasing an additional 1,749 shares during the period. Finally, MetLife Investment Management LLC grew its holdings in Aspen Aerogels by 6.3% during the fourth quarter. MetLife Investment Management LLC now owns 35,782 shares of the construction company’s stock valued at $425,000 after purchasing an additional 2,118 shares during the period. Institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.